Hypothalamic orexin-A binding sites are downregulated by chronic nicotine treatment in the rat

Neurosci Lett. 2001 Jan 26;298(1):1-4. doi: 10.1016/s0304-3940(00)01730-4.

Abstract

Chronic nicotine treatment (4 mg/kg per day; 14 days) significantly reduced the affinity and density of orexin-A binding sites in the anterior hypothalamus of rat brain. There was a significantly lower sensitivity of orexin-A binding to orexin peptides, to the related secretin and pituitary adenylate cyclase activating peptide, and to unrelated neuropeptide Y (NPY). This change correlated with selective downregulation of a fraction of hypothalamic NPY Y(1) receptors. In previous studies, we have demonstrated an increase in the levels of orexin-A peptide and NPY in discrete hypothalamic areas upon nicotine treatment. This finding contradicts an expected increase in the production of these orexigenic peptides in a model where an inverse relationship is observed between food consumption and nicotine treatment. This study provides a possible explanation to this inconsistency in that a decrease in affinity of orexin-A binding could reduce neural orexin signaling, which may contribute to decreased food intake observed in smokers and animals chronically treated with nicotine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Binding Sites
  • Binding, Competitive
  • Carrier Proteins / metabolism*
  • Down-Regulation
  • Hypothalamus / metabolism*
  • Intracellular Signaling Peptides and Proteins*
  • Neuropeptides / metabolism*
  • Nicotine / administration & dosage
  • Nicotine / pharmacology*
  • Orexins
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Carrier Proteins
  • Intracellular Signaling Peptides and Proteins
  • Neuropeptides
  • Orexins
  • Nicotine